share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 4:持股变动声明-董事 Cloonan Michael
美股sec公告 ·  06/24 17:21
Moomoo AI 已提取核心信息
Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
2024年6月20日,与bluebird bio,Inc. [BLUE]有关的Michael Cloonan参与了一项交易。公告中未披露交易的具体细节,包括操作类型、状态币、涉及的股份数量、股份性质、交易价格和交易后的参股金融。建议投资者等待进一步信息,以充分了解此事件对其关于bluebird bio股票的投资决策的影响。
2024年6月20日,与bluebird bio,Inc. [BLUE]有关的Michael Cloonan参与了一项交易。公告中未披露交易的具体细节,包括操作类型、状态币、涉及的股份数量、股份性质、交易价格和交易后的参股金融。建议投资者等待进一步信息,以充分了解此事件对其关于bluebird bio股票的投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息